Description:

Ksalol Tablets are primarily prescribed to address panic disorder, leveraging their benzodiazepine properties. They are specifically recommended for severe instances of panic disorder, particularly when patients are experiencing acute distress. Ksalol is intended for short-term use to alleviate severe anxiety and depression symptoms.

Mode of Action:

Ksalol functions by binding to γ-aminobutyric acid (GABAA) receptors located at the junction of α and γ subunits. Activation of these receptors results in the opening of chloride channels, which inhibits the transmission of neuronal impulses across synapses. By enhancing the effect of these receptors, Ksalol increases the frequency of chloride channel opening, leading to hyperpolarization of the membrane and reduced nerve conduction